PD-016 - Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study.

Authors :: Raimondi, A.
Di Maio, M.
Peverelli, G.
Morano, F.
Corallo, S.
Bergamo, F.
Cremolini, C.
Smiroldo, V.
Amatu, A.
Tampellini, M.
Fanchini, L.
Murialdo, R.
Clavarezza, M.
Noventa, S.
Adamo, V.
Ratti, M.
Petrelli, F.
Antonuzzo, L.
Palermo, M.
de Braud, F.
Source :: Annals of Oncology. 2019 Supplement, Vol. 30, piv115-iv115. 1p.
Publication Year :: 2019

Subjects :: *QUALITY of life
*COLORECTAL cancer
*METASTASIS
*CANCER patients
*ANTINEOPLASTIC combined chemotherapy protocols

Full Text Access

Tools